Related references
Note: Only part of the references are listed.The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk
Valerie A. Flores et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2015)
Treatment with Bazedoxifene and Conjugated Estrogens Results in Regression of Endometriosis in a Murine Model
Hanyia Naqvi et al.
BIOLOGY OF REPRODUCTION (2014)
Current and Evolving Approaches to Individualizing Estrogen Receptor-Based Therapy for Menopausal Women
Richard J. Santen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
Joann V. Pinkerton et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Differential effects of menopausal therapies on the endometrium
Sebastian Mirkin et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2014)
Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model
Kelly F. Ethun et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2013)
Breast Effects of Bazedoxifene-Conjugated Estrogens A Randomized Controlled Trial
JoAnn V. Pinkerton et al.
OBSTETRICS AND GYNECOLOGY (2013)
Tissue Selective Estrogen Complexes (TSECs) Differentially Modulate Markers of Proliferation and Differentiation in Endometrial Cells
Jaime Kulak et al.
REPRODUCTIVE SCIENCES (2013)
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention
J. V. Pinkerton et al.
CLIMACTERIC (2012)
Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review
Hugh S. Taylor et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model
Jaime Kulak et al.
ENDOCRINOLOGY (2011)
Endometriosis.
Linda C. Giudice
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile
Rogerio A. Lobo et al.
FERTILITY AND STERILITY (2009)
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women
David E. Archer et al.
FERTILITY AND STERILITY (2009)
Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis
Erkut Attar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Designing the ideal selective estrogen receptor modulator-an achievable goal?
Hugh S. Taylor
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Mechanisms of Disease Endometriosis
Serdar E. Bulun
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Return of chronic pelvic pain from endometriosis after raloxifene treatment - A randomized controlled trial
Pamela Stratton et al.
OBSTETRICS AND GYNECOLOGY (2008)
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety
Dale W. Stovall et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium - a pilot study
SR Davis et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2004)
Mechanisms of excessive estrogen formation in endometriosis
SE Bulun et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2002)
Share Paper
